AzTrials
AzTrials

DepressionNCT02708940

Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs

A study testing Participatory technology development in people with Depression and Anxiety, run by University of California, Los Angeles at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research project aims to evaluate the feasibility and effectiveness of a new approach to tailored mobile applications using the Chorus Participatory Mobile Framework. PHP and IOP program participants-patients and therapists--will be consented and enrolled by study staff. Read more about this study

Who is it for?
Any age
Conditions the study is for
Depression, Anxiety, Psychosis
What is being tested?
Participatory technology development
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
Feb 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients (over the age of 18) or parents of patients who are minors (between the ages of 6 and 17)
  • Enrolled in PHP or IOP programs at Resnick Neuropsychiatric Hospital
  • Agree to participate (minors will be required to have parental consent)
  • Patient participants will need to be English speaking because text and IVR messages and workshops will be conducted in English.
  • Patient must have cellular phone that can receive text messages
  • All PHP and IOP staff are eligible and will be invited to participate in workshops and complete surveys.

Who cannot join

  • Declines consent or is unwilling to participate in the study
  • Does not speak English. Language other than English is an exclusion given resources and capacity of the study
  • Patients without a cellular phone that can receive text messages
  • Not receiving texts or IVR messages from their program is an exclusion given that it is the intervention we are evaluating
  • Patients under the age of 6.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCLA Partial Hospitalization and Intensive Outpatient Programs

    Los Angeles, California, 90095

Other trials in United States

About this study

This research project aims to evaluate the feasibility and effectiveness of a new approach to tailored mobile applications using the Chorus Participatory Mobile Framework. PHP and IOP program participants-patients and therapists--will be consented and enrolled by study staff. Study participants will be invited to workgroups specific to their program to discuss the usability of Chorus and be asked to complete surveys on demographics, satisfaction, self-efficacy, and involvement with Chorus and usability of the tool.

Read the detailed description

The Partial Hospitalization Program (PHP) and Intensive Outpatient Program (IOP) in the Neuropsychatric Hospital at UCLA provide psychiatric services for adults and children with acute mental illness. These include voluntary programs that support individuals in their recovery with the goal to assist patients in achieving the highest level of independence. Most programs operate Monday through Friday between four to eight hours a day. Recently, the PHP and IOP programs have decided to start including mobile messaging as a part of care, helping patients to feel supported even after they have left the hospital for the day.

The purpose of this study is to evaluate the feasibility and effectiveness of their ongoing use of the Chorus Participatory Mobile Framework to support clinical care. Chorus is a framework and web application that allows users to rapidly create a broad range of automated text messaging (SMS), interactive voice (IVR), or mobile web applications using a simple and accessible visual interface without requiring any server programming. There will be two broad populations using Chorus: (1) programs (e.g. OCD Intensive Treatment Program) in which all participants will receive participatory mobile messaging and (2) programs (e.g. Adult Acute PHP) in which patients will be randomized to receive either participatory mobile messaging or no mobile messaging. Across all programs, Kandace Whiting and Armen Arevian will train PHP and IOP therapists starting with creating simple, basic, useful messaging content in Chorus to support patients in achieving program goals. Examples of messages include Cognitive Behavioral Therapy (CBT), symptom management, and stress management cues to patients in the Obsessive Compulsive Disorder Clinic, patients in the Adult Eating Disorder Clinic, and parents from The Achievement, Behavior, Cognition (ABC) Child Programs.

All participating patients receiving participatory mobile messaging will work with program staff one-on-one to tailor SMS and IVR content and design based on their own preferences. By being able to personalize the messaging, the Chorus Participatory Mobile Framework meets the capacities and preferences of the users rather than a "one-size" approach requiring adaptation of the users to the technology. Both therapists and patients will be invited to up to bi-weekly, in-person workshops specific to their program to provide feedback and input. The goal of these workshops is to further develop and refine the novel mobile interventions based on stakeholder input. The Chorus Participatory Framework will be used during the workshops to develop and test the application in real-time. Workshops will be audio and/or video recorded to document the process.

Being tested
Participatory technology development, Usual Care
Medical subject headings
Depression, Anxiety Disorders, Psychotic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Participatory technology developmentOther

    Creating mobile support tools by patients and their therapists

  • Usual CareOther

    Usual care as part of the UCLA PHP and IOP programs

Study groups in NCT02708940
Study groupRoleWhat they receive
Usual careActive comparatorControl arm - these patients will get usual care as part of the PHP and IOP programs at UCLA. They will not receive mobile support messages.
Receives: Other: Usual Care
Participatory technology developmentActive comparatorIntervention - Patients will have access to a website that allows them to co-create mobile support messages with their therapist to support their care as part of the PHP and IOP programs at UCLA.
Receives: Other: Participatory technology development

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in homework completion rate

    the change in the degree to which patients complete tasks assigned to them by their provider as part of their treatment

    Measured: Collected on each program attendance day (up to daily), through discharge from program, an average of 12 weeks

Secondary outcomes (9)
  1. length of stay

    length of stay (in terms of days and hours/day of program attendance)

    Measured: At discharge from program, an average of 12 weeks

  2. time to discharge

    time to step down from partial hospitalization program to intensive outpatient program and time to discharge from program

    Measured: From admission to program until discharge from program, assessed up to 20 weeks

  3. Number of patient visits to health care organizations outside of clinic

    the number of services that patients utilize outside of the clinic, including ED visits and inpatient hospitalizations.

    Measured: at patient disenrollment from study, approximately 3 months after discharge from program, up to 40 weeks

  4. Types of health care services patients utilize outside of clinic

    the types of services that patients utilize outside of the clinic, including ED visits and inpatient hospitalizations.

    Measured: at patient disenrollment from study, approximately 3 months after discharge from program, up to 40 weeks

  5. change in depression symptoms

    PHQ-9 to measure changes in depression symptoms

    Measured: Upon admission to program, at mid-point of stay in program, at discharge from program (may also be up to weekly during stay), an average of 12 weeks; and 3 months after discharge from programa

  6. Change in Patient Treatment Self-Efficacy

    change patient treatment self-efficacy from week-to-week during program

    Measured: weekly during stay in program, through discharge from program, an average of 12 weeks

  7. Difference in Patient Satisfaction with Program between Intervention vs Control groups

    comparing patient satisfaction with services and support between the intervention and control groups

    Measured: at discharge from program, an average of 12 weeks

  8. Messaging Application Usability

    Weekly survey of patients in the intervention arm and all providers to assess the usability of the messaging application

    Measured: weekly during stay in program, through discharge from program, an average of 12 weeks

  9. Patient Involvement in Message Development

    Completed by patients in the intervention arm and by provider for each patient in intervention arm to assess the extent of patient involvement in the development of message content and schedule, and use of messaging application

    Measured: weekly during stay in program, through discharge from program, an average of 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionSep 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02708940
Sponsor's protocol ID
IRB#14-001879
Status last verified
Nov 2023
First submitted
4 Feb 2016
Last updated
7 Nov 2023
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Participatory technology development in people with Depression and Anxiety, run by University of California, Los Angeles at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in homework completion rate (time frame: Collected on each program attendance day (up to daily), through discharge from program, an average of 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in